Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

13 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
FET-PET for malignant glioma treatment planning.
Niyazi M, Geisler J, Siefert A, Schwarz SB, Ganswindt U, Garny S, Schnell O, Suchorska B, Kreth FW, Tonn JC, Bartenstein P, la Fougère C, Belka C. Niyazi M, et al. Among authors: garny s. Radiother Oncol. 2011 Apr;99(1):44-8. doi: 10.1016/j.radonc.2011.03.001. Epub 2011 Mar 30. Radiother Oncol. 2011. PMID: 21458093
Simultaneous stereotactic radiosurgery of multiple brain metastases using single-isocenter dynamic conformal arc therapy: a prospective monocentric registry trial.
Bodensohn R, Kaempfel AL, Fleischmann DF, Hadi I, Hofmaier J, Garny S, Reiner M, Forbrig R, Corradini S, Thon N, Belka C, Niyazi M. Bodensohn R, et al. Among authors: garny s. Strahlenther Onkol. 2021 Jul;197(7):601-613. doi: 10.1007/s00066-021-01773-6. Epub 2021 Apr 21. Strahlenther Onkol. 2021. PMID: 33884441 Free PMC article. Clinical Trial.
Stereotactic radiosurgery versus whole-brain radiotherapy in patients with 4-10 brain metastases: A nonrandomized controlled trial.
Bodensohn R, Kaempfel AL, Boulesteix AL, Orzelek AM, Corradini S, Fleischmann DF, Forbrig R, Garny S, Hadi I, Hofmaier J, Minniti G, Mansmann U, Pazos Escudero M, Thon N, Belka C, Niyazi M. Bodensohn R, et al. Among authors: garny s. Radiother Oncol. 2023 Sep;186:109744. doi: 10.1016/j.radonc.2023.109744. Epub 2023 Jun 15. Radiother Oncol. 2023. PMID: 37330054 Free article. Clinical Trial.
Dosimetric feasibility analysis and presentation of an isotoxic dose-escalated radiation therapy concept for glioblastoma used in the PRIDE trial (NOA-28; ARO-2022-12).
Bodensohn R, Fleischmann DF, Maier SH, Anagnostatou V, Garny S, Nitschmann A, Büttner M, Mücke J, Schönecker S, Unger K, Hoffmann E, Paulsen F, Thorwarth D, Holzgreve A, Albert NL, Corradini S, Tabatabai G, Belka C, Niyazi M. Bodensohn R, et al. Among authors: garny s. Clin Transl Radiat Oncol. 2023 Dec 3;45:100706. doi: 10.1016/j.ctro.2023.100706. eCollection 2024 Mar. Clin Transl Radiat Oncol. 2023. PMID: 38116137 Free PMC article.
13 results